Fractyl Health, Inc. (GUTS)
1.08
+0.11
(+11.87%)
USD |
NASDAQ |
Nov 18, 16:00
1.05
-0.03
(-2.78%)
After-Hours: 07:47
Fractyl Health Enterprise Value : 42.34M for Nov. 18, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 18, 2026 | 42.34M |
| November 17, 2026 | 40.82M |
| November 16, 2026 | 41.17M |
| November 13, 2026 | 40.00M |
| November 12, 2026 | 38.79M |
| November 11, 2026 | 39.71M |
| November 10, 2026 | 38.77M |
| November 09, 2026 | 39.92M |
| November 06, 2026 | 40.35M |
| November 05, 2026 | 39.90M |
| November 04, 2026 | 40.92M |
| November 03, 2026 | 39.93M |
| November 02, 2026 | 40.52M |
| October 30, 2026 | 40.97M |
| October 29, 2026 | 41.17M |
| October 28, 2026 | 39.82M |
| October 27, 2026 | 39.69M |
| October 26, 2026 | 42.21M |
| October 23, 2026 | 42.34M |
| October 22, 2026 | 43.01M |
| October 21, 2026 | 43.27M |
| October 20, 2026 | 45.66M |
| October 19, 2026 | 46.32M |
| October 16, 2026 | 48.58M |
| October 15, 2026 | 83.20M |
| Date | Value |
|---|---|
| October 14, 2026 | 82.14M |
| October 13, 2026 | 81.41M |
| October 12, 2026 | 86.52M |
| October 09, 2026 | 86.65M |
| October 08, 2026 | 84.13M |
| October 07, 2026 | 87.98M |
| October 06, 2026 | 88.64M |
| October 05, 2026 | 88.51M |
| October 02, 2026 | 92.74M |
| October 01, 2026 | 99.67M |
| September 30, 2026 | 114.68M |
| September 29, 2026 | 96.09M |
| September 28, 2026 | 88.32M |
| September 25, 2026 | 90.64M |
| September 24, 2026 | 88.15M |
| September 23, 2026 | 90.64M |
| September 22, 2026 | 101.33M |
| September 21, 2026 | 104.30M |
| September 18, 2026 | 108.79M |
| September 17, 2026 | 107.33M |
| September 16, 2026 | 102.84M |
| September 15, 2026 | 103.23M |
| September 14, 2026 | 110.63M |
| September 11, 2026 | 115.13M |
| September 10, 2026 | 115.62M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Co-Diagnostics, Inc. | 2.291M |
| Spectral AI, Inc. | 48.84M |
| Omnicell, Inc. | 1.457B |
| Oncolytics Biotech, Inc. | 56.19M |
| Sangamo Therapeutics, Inc. | 37.32M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -14.15M |
| Total Expenses (Quarterly) | 14.15M |
| EPS Diluted (Quarterly) | -1.068 |
| Earnings Yield | -529.9% |
| Normalized Earnings Yield | -554.46 |